Sanguinaria Canadensis Herb (Sanguinaria canadensis): Benefits, Dosage, Safety & Evidence

Questions fréquentes

How does bloodroot work as an antimicrobial?

Sanguinaria canadensis contains isoquinoline alkaloids, primarily sanguinarine and chelerythrine, which exert antimicrobial effects through DNA intercalation and inhibition of bacterial enzymes. Sanguinarine disrupts bacterial cell membranes and inhibits adenosine triphosphatase activity, making it effective against oral pathogens. These compounds also demonstrate anti-inflammatory properties by modulating NF-kappaB signaling pathways. Evidence level: C (preclinical and in vitro studies support these mechanisms, though human clinical data remains limited).

Does bloodroot interact with any medications?

Sanguinaria canadensis has significant potential for drug interactions due to its hepatotoxic effects. The alkaloids sanguinarine and chelerythrine may inhibit cytochrome P450 enzymes, potentially altering the metabolism of numerous pharmaceutical drugs. Concurrent use with hepatotoxic medications, including acetaminophen, statins, and certain antibiotics, may increase the risk of liver damage. Patients taking any prescription medications should avoid internal use of bloodroot without qualified medical supervision. Evidence level: C.

What is the safe dosage of bloodroot?

Internal use of Sanguinaria canadensis is extremely dangerous and not recommended without qualified medical supervision. Traditional use involved very small doses, typically 0.03-0.3 grams of dried root, but toxicity can occur even at low doses. For topical applications in oral hygiene products, sanguinarine-containing mouthwashes typically contain 0.03-0.075% concentration. Self-medication with bloodroot extracts, tinctures, or raw plant material carries significant risk of severe gastrointestinal toxicity and liver damage. Evidence level: Traditional/C.

Is bloodroot safe during pregnancy and breastfeeding?

Sanguinaria canadensis is contraindicated during pregnancy and breastfeeding. The alkaloid sanguinarine has demonstrated uterine stimulant properties and abortifacient effects in traditional use and animal studies. Historical use included bloodroot as an emmenagogue to induce menstruation and terminate pregnancies. The plant's uterine-stimulating compounds may cause miscarriage or premature labor. Additionally, sanguinarine can pass into breast milk and may cause toxicity in nursing infants. Pregnant or breastfeeding individuals should avoid all forms of bloodroot. Evidence level: C/Traditional.

What is bloodroot used for medicinally?

Sanguinaria canadensis has been used traditionally by Indigenous peoples of North America for respiratory conditions including croup, whooping cough, and bronchitis. Topically, the red sap has been applied as an escharotic agent for removing skin growths, warts, and suspicious lesions. Modern applications include sanguinarine as an ingredient in natural oral care products for its antimicrobial and antiplaque properties. However, internal use carries significant toxicity risks, and escharotic use for skin cancer is not medically recommended. Evidence level: C/Traditional.

Fiche d'information compilée à partir de PubMed

Cette fiche a été compilée à partir de résumés PubMed (NIH) avec l'assistance d'une IA. Chaque affirmation factuelle est citée par un article PubMed réel (voir la liste des sources). Elle n'a pas encore été révisée par un humain — confirmez auprès d'un professionnel de santé avant utilisation.

Compilé à partir de 30 articles PubMed · modèle : gemma4:31b

Résumé

Sanguinaria canadensis (bloodroot) is a North American flowering herb containing bioactive alkaloids used historically for various medicinal purposes, though it is associated with significant tissue toxicity [PMID:23169210, PMID:33128472].

Contexte

Bloodroot is a perennial flowering plant native to the eastern forests of North America [PMID:23169210, PMID:20932193, PMID:30727307].

Usages traditionnels

Historically, Native Americans used bloodroot for wound healing, pain and fever relief, and blood purification and tonification [PMID:23169210, PMID:27618894]. It has also been used for its antimicrobial, antihypertensive, anti-inflammatory, and antineoplastic properties [PMID:34847001].

Composés actifs

The plant's rhizome contains benzophenanthridine and protopin alkaloids [PMID:27618894], specifically sanguinarine and chelerythrine [PMID:17253712, PMID:27671816]. It also produces flavonoid compounds with phenolic structures [PMID:15928624].

Mécanisme d'action

Sanguinarine acts as a DNA and RNA intercalator (in its iminium ion form) and binds to functional proteins such as hemoglobin, lysozyme, and serum albumins [PMID:27671816]. It may induce ferroptosis in prostate cancer by regulating the ROS/BACH1/HMOX1 signaling pathway [PMID:38195593] and exhibits proapoptotic, growth inhibitory, and antiangiogenic effects on tumor cells [PMID:28636454, PMID:26798435].

Preuves cliniques

Preuve DSkin Cancer

Marketed as 'black salve' for skin cancer, but clinical data primarily consist of case studies with unfavorable outcomes; however, preclinical studies suggest sanguinarine may be efficacious at micromolar doses [PMID:33128472, PMID:24175872].

Preuve COral Health (Plaque/Gingivitis)

Sanguinarine shows broad antimicrobial activity in vitro; however, clinical effectiveness of toothpastes and mouthwashes containing the extract against dental plaque and gingivitis has shown conflicting results [PMID:2700895, PMID:22318955].

Preuve DImmune Response

In vitro studies indicate that bloodroot extracts can enhance proliferation and cytokine production (TNF, IL-1beta, IL-10) in human peripheral blood mononuclear cells [PMID:20111671, PMID:19766513].

Sécurité et effets indésirables

Bloodroot is a known escharotic that can cause significant tissue destruction, necrosis, ulceration, burns, and irreversible scarring or keloid formation [PMID:23169210, PMID:34847001, PMID:25046467, PMID:36743972]. Other reported toxicities include mouthwash-induced leukoplakia [PMID:27618894] and a theoretical risk of inducing epidemic dropsy due to sanguinarine content [PMID:29603306].

Synthèse des preuves

Evidence is primarily based on historical use, in vitro/preclinical studies, and case reports of toxicity. There is a lack of objective clinical evidence supporting its use as a skin cancer treatment, while there is strong evidence of its potential for causing severe cutaneous tissue damage.

Sources PubMed

1.PMID: 23169210 (2012) — Bloodroot. · Dermatitis : contact, atopic, occupational, drug
2.PMID: 34847001 (2021) — Botanical Briefs: Bloodroot (Sanguinaria canadensis). · Cutis
3.PMID: 25046467 (2014) — Bloodroot associated eschar. · Dermatology online journal
4.PMID: 33128472 (2021) — Dermatologic uses of bloodroot: a review and reappraisal. · International journal of dermatology
5.PMID: 27618894 (2016) — Sanguinaria canadensis: Traditional Medicine, Phytochemical Composition, Biological Activities and Current Uses. · International journal of molecular sciences
6.PMID: 24175872

Sanguinaria Canadensis Herb

Sources et citations

Calculer une dose sûre de Sanguinaria Canadensis Herb